Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

Nagai, Makiko, Re, Diane B, Nagata, Tetsuya, Chalazonitis, Alcmène, Jessell, Thomas M, Wichterle, Hynek, Przedborski, Serge·2007·Nature Neuroscience
DOI 10.1038/nn1876

Cited by (1,000)

Items 401–500 of 1,000

  1. Motor neuron impairment mediated by a sumoylated fragment of the glial glutamate transporter EAAT2
    Emily Foran, Alexey I. Bogush, Michael Goffredo, Paola Roncaglia, Stefano Gustincich, Piera Pasinelli, Davide Trotti · 2011 · Glia
  2. Therapeutic Potential of Mesenchymal Stromal Cells and MSC Conditioned Medium in Amyotrophic Lateral Sclerosis (ALS) - In Vitro Evidence from Primary Motor Neuron Cultures, NSC-34 Cells, Astrocytes and Microglia
    Hui Juan Sun, Karelle Bénardais, Nancy Stanslowsky, Nadine Thau‐Habermann, Niko Hensel, Dongya Huang, Peter Claus, Reinhard Dengler, Martin Stangel, Susanne Petri · 2013 · PLoS ONE
  3. Amyotrophic Lateral Sclerosis: New Insights into Underlying Molecular Mechanisms and Opportunities for Therapeutic Intervention
    Mauro Cozzolino, Maria Grazia Pesaresi, Valeria Gerbino, Julian Großkreutz, Maria Teresa Carrı̀ · 2012 · Antioxidants and Redox Signaling
  4. Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cord
    Jianjun Zhai, Anna‐Lena Ström, Renée Kilty, Priya Venkatakrishnan, James White, William V. Everson, Eric J. Smart, Haining Zhu · 2009 · FEBS Journal
  5. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS
    Keiichi Kadoyama, Hiroshi Funakoshi, Wakana Ohya, Toshikazu Nakamura · 2007 · Neuroscience Research
  6. Gender-specific perturbations in modulatory inputs to motoneurons in a mouse model of amyotrophic lateral sclerosis
    Lissa R. Herron, Gareth Brian Miles · 2012 · Neuroscience
  7. Delayed transplantation of precursor cell‐derived astrocytes provides multiple benefits in a rat model of Parkinsons
    Christoph Pröschel, Jennifer L. Stripay, Chung‐Hsuan Shih, Joshua C. Munger, Mark Noble · 2014 · EMBO Molecular Medicine
  8. Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis
    Carmen Rodríguez‐Cueto, Irene Santos‐García, Laura García‐Toscano, Francisco Espejo‐Porras, MLuz Bellido, Javier Fernández‐Ruíz, Eduardo Muñóz, Eva de Lago · 2018 · Biochemical Pharmacology
  9. Inhibitory Synaptic Regulation of Motoneurons: A New Target of Disease Mechanisms in Amyotrophic Lateral Sclerosis
    Lee J. Martin, Qing Chang · 2011 · Molecular Neurobiology
  10. Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats
    Cao Huang, Jianbin Tong, Fangfang Bi, Qinxue Wu, Bo Huang, Hongxia Zhou, Xu‐Gang Xia · 2012 · Human Molecular Genetics
  11. Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells
    Wenting Guo, Laura Fumagalli, Robert Ciarán Prior, Ludo Van Den Bosch · 2017 · Frontiers in Neuroscience
  12. Sigma 1 receptor as a therapeutic target for amyotrophic lateral sclerosis
    Mireia Herrando‐Grabulosa, Núria Gaja‐Capdevila, José Miguel Vela, Xavier Navarro · 2020 · British Journal of Pharmacology
  13. TIMP-1: A key cytokine released from activated astrocytes protects neurons and ameliorates cognitive behaviours in a rodent model of Alzheimer’s disease
    Pampa Saha, Sukanya Sarkar, Ramesh Kumar Paidi, Subhas Chandra Biswas · 2020 · Brain Behavior and Immunity
  14. Cerebrospinal Fluid from sporadic Amyotrophic Lateral Sclerosis patients induces degeneration of a cultured motor neuron cell line
    Kandasamy Vijayalakshmi, Phalguni Anand Alladi, Talakad N. Sathyaprabha, Jamuna R. Subramaniam, Atchayaram Nalini, T.R. Raju · 2009 · Brain Research
  15. Pathogenic TARDBP Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: Disease-Associated Pathways
    Sami J. Barmada, Steven M. Finkbeiner · 2010 · Reviews in the Neurosciences
  16. AAV‐mediated expression of wild‐type and ALS‐linked mutant VAPB selectively triggers death of motoneurons through a Ca2+‐dependent ER‐associated pathway
    Karine Langou, Anice Moumen, Christophe Pellegrino, Julianne Aebischer, Igor Medina, Patrick Aebischer, Cédric Raoul · 2010 · Journal of Neurochemistry
  17. Neuronal expression of Fig4 is both necessary and sufficient to prevent spongiform neurodegeneration
    Cole Ferguson, Guy M. Lenk, J. M. Jones, Adrienne E. Grant, Jesse J. Winters, James J. Dowling, Roman J. Giger, Miriam H. Meisler · 2012 · Human Molecular Genetics
  18. Astrocytes as targets for drug discovery
    Kirill Gorshkov, Francis Aguisanda, Natasha Thorne, Wei Zheng · 2018 · Drug Discovery Today
  19. Mitochondrial Dysfunction, Neurogenesis, and Epigenetics: Putative Implications for Amyotrophic Lateral Sclerosis Neurodegeneration and Treatment
    Calió, Michele Longoni, Henriques, Elisandra, Siena, Amanda, Bertoncini, Clélia Rejane Antonio, Gil-Mohapel, Joana, Rosenstock, Tatiana Rosado · 2020 · Frontiers in Neuroscience
  20. Aquaporin‐4 Overexpression in Rat ALS Model
    Charles Nicaise, Muhammad Shahnawaz Soyfoo, Michèle Authelet, Robert De Decker, Danijela Bataveljić, Christine Delporte, Roland Pochet · 2008 · The Anatomical Record
  21. Increased Expression of MicroRNA-29a in ALS Mice: Functional Analysis of Its Inhibition
    K.B. Nolan, Mollie R. Mitchem, Eva Maria Jimenez-Mateos, David Clifford Henshall, Caoimhín G. Concannon, Jochen H.M. Prehn · 2014 · Journal of Molecular Neuroscience
  22. Intracerebroventricular Injection of Encapsulated Human Mesenchymal Cells Producing Glucagon-Like Peptide 1 Prolongs Survival in a Mouse Model of ALS
    Sarah Knippenberg, Nadine Thau, Reinhard Dengler, Thomas Brinker, Susanne Petri · 2012 · PLoS ONE
  23. Catalytic Antioxidants and Neurodegeneration
    Tamara R. Golden, Manisha Patel · 2008 · Antioxidants and Redox Signaling
  24. EAAT2 and the Molecular Signature of Amyotrophic Lateral Sclerosis
    Lauren Taylor Rosenblum, Davide Trotti · 2017 · Advances in neurobiology
  25. Immune mechanisms and shared immune targets in neurodegenerative diseases
    Howard L. Weiner · 2024 · Nature Reviews Neurology
  26. Neuron–astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation
    Kakulavarapu V. Rama Rao, Tammy Kielian · 2015 · Clinical and Experimental Neuroimmunology
  27. G protein-coupled receptor signalling in astrocytes in health and disease: A focus on metabotropic glutamate receptors
    Sophie J. Bradley, R. A. John Challiss · 2012 · Biochemical Pharmacology
  28. Progress and Promise Towards Safe Induced Pluripotent Stem Cells for Therapy
    Ali Seifinejad, Mohammadsharif Tabebordbar, Hossein Baharvand, Laurie A. Boyer, Ghasem Hosseini Salekdeh · 2010 · Stem Cell Reviews and Reports
  29. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice
    Chengyun Zheng, Mattias K. Sköld, Jian Li, Inger Nennesmo, Bengt Fadeel, Jan‐Inge Henter · 2007 · Biochemical and Biophysical Research Communications
  30. Neuroimmune and Inflammatory Signals in Complex Disorders of the Central Nervous System
    Ana C. Liberman, Emiliano Trías, Luana da Silva Chagas, Pablo Trindade, Marissol dos Santos Pereira, Damián Refojo, Cecilia Hedin‐Pereira, Claudio Alberto Serfaty · 2018 · NeuroImmunoModulation
  31. Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders
    Qiang, Liang, Fujita, Ryousuke, Abeliovich, Asa · 2013 · Neuron
  32. Gender-Specific Mechanism of Synaptic Impairment and Its Prevention by GCSF in a Mouse Model of ALS
    Nikolay V. Naumenko, Eveliina Pollari, Antti Kurronen, Raisa Giniatullina, Anastasia Shakirzyanova, Johanna M. Magga, Jari Koıstınaho, Rashid A. Giniatullin · 2011 · Frontiers in Cellular Neuroscience
  33. The role of D-serine and glycine as co-agonists of NMDA receptors in motor neuron degeneration and amyotrophic lateral sclerosis (ALS)
    Praveen Paul, Jacqueline de Belleroche · 2014 · Frontiers in Synaptic Neuroscience
  34. Targeted Ablation of Oligodendrocytes Triggers Axonal Damage
    Aniket Ghosh, Natalia Manrique‐Hoyos, Aaron Voigt, Jörg Bernhard Schulz, Mario Kreutzfeldt, Doron Merkler, Mikael Simons · 2011 · PLoS ONE
  35. Integrative gene–tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis
    Lili C. Kudo, Liubov V. Parfenova, Nancy Vi, Kimbley Lau, Justine Pomakian, Paul N. Valdmanis, Guy Armand Rouleau, Harry V. Vinters, Martina Wiedau‐Pazos, Stanislav L. Karsten · 2010 · Human Molecular Genetics
  36. Amyotrophic lateral sclerosis pathogenesis: a journey through the secretory pathway
    Nassif, Melissa, Matus, Soledad, Castillo, Karen, Hetz, Claudio · 2010 · Antioxidants & Redox Signaling
  37. Molecular chaperone Hsp110 rescues a vesicle transport defect produced by an ALS-associated mutant SOD1 protein in squid axoplasm
    Yuyu Song, Maria Nagy, Weiming Ni, Navneet K. Tyagi, Wayne A. Fenton, Francesc López‐Giráldez, John D. Overton, Arthur L. Horwich, Scott T. Brady · 2013 · Proceedings of the National Academy of Sciences
  38. Manganese activates the mitochondrial apoptotic pathway in rat astrocytes by modulating the expression of proteins of the Bcl-2 family
    Laura E. González, Adela Ana Juknat, Andrea J. Venosa, Noemí Verrengia, Mónica L. Kotler · 2008 · Neurochemistry International
  39. Low-level overexpression of wild type TDP-43 causes late-onset, progressive neurodegeneration and paralysis in mice
    Chunxing Yang, Tao Qiao, Jia Hui Yu, Hongyan Wang, Yansu Guo, Johnny S. Salameh, Jake Metterville, Sepideh Parsi, Issa Olakunle Yusuf, Robert H. Brown et al. · 2022 · PLoS ONE
  40. Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis
    Rosa Luisa Potenza, Monica Armida, Antonella Ferrante, Antonella Pèzzola, Alessandra Matteucci, Maria Puopolo, Patrizia Popoli · 2013 · Journal of Neuroscience Research
  41. Activated Protein C Analog Protects From Ischemic Stroke and Extends the Therapeutic Window of Tissue-Type Plasminogen Activator in Aged Female Mice and Hypertensive Rats
    Yaoming Wang, Zhen Zhao, Nienwen Chow, Padmesh S. Rajput, John H. Griffin, Patrick D. Lyden, Berislav V. Zloković · 2013 · Stroke
  42. IN VITRO AND IN VIVO MODELS OF AMYOTROPHIC LATERAL SCLEROSIS: AN UPDATED OVERVIEW
    Auderlan Mendonça de Gois, Deise Maria Furtado de Mendonça, Marco Aurélio M. Freire, José Ronaldo dos Santos · 2020 · Brain Research Bulletin
  43. Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies
    Andrijana Lazic, Vanda Balint, Danijela Stanisavljević Ninković, Mina Perić, Milena J. Stevanović · 2022 · International Journal of Molecular Sciences
  44. Neuroprotective Effect of Bexarotene in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
    Javier Riancho, María Ruiz‐Soto, Maria Teresa Berciano, José Berciano, Miguel Lafarga · 2015 · Frontiers in Cellular Neuroscience
  45. Phenotypic transition of microglia into astrocyte-like cells associated with disease onset in a model of inherited ALS
    Emiliano Trías, Pablo Díaz‐Amarilla, Silvia Olivera‐Bravo, Eugenia Isasi, Derek A. Drechsel, Nathan I. Lopez, C. Samuel Bradford, Kyle E. Ireton, Joseph S. Beckman, Luis Barbeito · 2013 · Frontiers in Cellular Neuroscience
  46. Increased Axonal Mitochondrial Mobility Does Not Slow Amyotrophic Lateral Sclerosis (ALS)-like Disease in Mutant SOD1 Mice
    Yi-Bing Zhu, Zu‐Hang Sheng · 2011 · Journal of Biological Chemistry
  47. Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery
    J. Simon Lunn, Michael P. Hefferan, Martin Maršala, Eva L. Feldman · 2009 · Growth Factors
  48. A Refined Bead-Free Method to Identify Astrocytic Exosomes in Primary Glial Cultures and Blood Plasma
    Cory M. Willis, Antoine Ménoret, Evan R. Jellison, Alexandra M. Nicaise, Anthony T. Vella, Stephen J. Crocker · 2017 · Frontiers in Neuroscience
  49. Enhancing CNS Repair in Neurological Disease
    Xiaohua Xu, Arthur E. Warrington, Allan J. Bieber, Moses Rodriguez · 2011 · CNS Drugs
  50. Characterization of human iPSC-derived astrocytes with potential for disease modeling and drug discovery
    Vincent Soubannier, Gilles Maussion, Mathilde Chaineau, Veronika Sigutova, Guy Armand Rouleau, Thomas M. Durcan, Stefano Stifani · 2020 · Neuroscience Letters
  51. Recovery of Depleted miR-146a in ALS Cortical Astrocytes Reverts Cell Aberrancies and Prevents Paracrine Pathogenicity on Microglia and Motor Neurons
    Marta Barbosa, Cátia Gomes, Catarina Sequeira, Joana Gonçalves‐Ribeiro, Carolina Campos Pina, Luís A. R. Carvalho, Rui Moreira, Sandra Henriques Vaz, Ana Rita Vaz, Dora Maria Tuna Oliveira Brites · 2021 · Frontiers in Cell and Developmental Biology
  52. Limited Phenotypic Effects of Selectively Augmenting the SMN Protein in the Neurons of a Mouse Model of Severe Spinal Muscular Atrophy
    Andrew J. H. Lee, Tomoyuki Awano, Gyu-Hwan Park, Umrao R. Monani · 2012 · PLoS ONE
  53. Astrocyte signaling and neurodegeneration
    Liliana Brambilla, Francesca Martorana, Daniela Rossi · 2013 · Prion
  54. A study to investigate the reasons for bank frauds and the implementation of preventive security controls in Indian banking industry
    A. Khanna, B. Arora · 2009 · International journal of business science & applied management.
  55. Reactive Astrocytes and Emerging Roles in Central Nervous System (CNS) Disorders
    Liddelow, Shane A., Olsen, Michelle L., Sofroniew, Michael V. · 2024 · Cold Spring Harbor Perspectives in Biology
  56. A Stem Cell-Based Screening Platform Identifies Compounds that Desensitize Motor Neurons to Endoplasmic Reticulum Stress
    Thams, Sebastian, Lowry, Emily Rhodes, Larraufie, Marie-Hélène, Spiller, Krista J., Li, Hai, Williams, Damian J., Hoang, Phuong, Jiang, Elise, Williams, Luis A., Sandoe, Jackson et al. · 2019 · Molecular Therapy
  57. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis
    Kazunori Tanaka, Takuya Kanno, Yoshiko Yanagisawa, Kaori Yasutake, Shinji Hadano, Fumihito Yoshii, Joh‐E Ikeda · 2011 · Experimental Neurology
  58. Oxidative Stress and Autophagic Alteration in Brainstem of SOD1-G93A Mouse Model of ALS
    Ting An, Pengxiao Shi, Weisong Duan, Shipan Zhang, Pin Yuan, Zhongyao Li, Dongxia Wu, Zuoshang Xu, Chunyan Li, Yansu Guo · 2014 · Molecular Neurobiology
  59. Research Advances in Amyotrophic Lateral Sclerosis, 2009 to 2010
    Rebecca Traub, Hiroshi Mitsumoto, Lewis P. Rowland · 2010 · Current Neurology and Neuroscience Reports
  60. Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies
    Shingo Kariya, Diane Bérangère Ré, Arnaud Jacquier, Katelyn N. Nelson, Serge Przedborski, Umrao R. Monani · 2012 · Human Molecular Genetics
  61. Selective vulnerability of motoneuron and perturbed mitochondrial calcium homeostasis in amyotrophic lateral sclerosis: implications for motoneurons specific calcium dysregulation
    Manoj K. Jaiswal · 2014 · Molecular and Cellular Therapies
  62. Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown
    Samantha J. Merwin, Teresa Obis, Yanelli Nunez, Diane Bérangère Ré · 2017 · Archives of Toxicology
  63. Human Motor Neurons With SOD1-G93A Mutation Generated From CRISPR/Cas9 Gene-Edited iPSCs Develop Pathological Features of Amyotrophic Lateral Sclerosis
    Byung Woo Kim, Jiwon Ryu, Ye Eun Jeong, Juhyun Kim, Lee J. Martin · 2020 · Frontiers in Cellular Neuroscience
  64. Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines
    Avital Licht-Murava, Samantha M. Meadows, Fernando Palaguachi, Soomin C. Song, Yaron Bram, Constance Q. Zhou, Stephanie Jackvony, Robert E. Schwartz, Robert C. Froemke, Adam L. Orr et al. · 2023 · Science Advances
  65. Astrocytic modulation of neuronal signalling
    Sushmitha S. Purushotham, Yossi Buskila · 2023 · Frontiers in Network Physiology
  66. Stem Cell-Derived Motor Neurons: Applications and Challenges in Amyotrophic Lateral Sclerosis
    Jason R. Thonhoff, Luis D. Ojeda, Ping Wu · 2009 · Current Stem Cell Research & Therapy
  67. A MicroRNA124 Target Sequence Restores Astrocyte Specificity of gfaABC1D-Driven Transgene Expression in AAV-Mediated Gene Transfer
    Grit Taschenberger, Julia Tereshchenko, Sebastian Kügler · 2017 · Molecular Therapy — Nucleic Acids
  68. miR126-5p Downregulation Facilitates Axon Degeneration and NMJ Disruption via a Non–Cell-Autonomous Mechanism in ALS
    Roy Maimon, Ariel Ionescu, Avichai Bonnie, Sahar Sweetat, Shane Wald-Altman, Shani Inbar, Tal Gradus, Davide Trotti, Miguel Weil, Oded Behar et al. · 2018 · Journal of Neuroscience
  69. Light therapy and supplementary riboflavin in the SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis (FALS)
    Helina Moges, Olavo M. Vasconcelos, William W. Campbell, Rosemary C. Borke, Jennifer Anne McCoy, Lauren Kaczmarczyk, Ji Feng, Juanita J. Anders · 2009 · Lasers in Surgery and Medicine
  70. Astrocytes usurp neurons as a disease focus
    Shane Antony Liddelow, Michael V. Sofroniew · 2019 · Nature Neuroscience
  71. Motor neuron–immune interactions: the vicious circle of ALS
    Ana G. Barbeito, Pinar Mesci, Séverine Boillée · 2010 · Journal of Neural Transmission
  72. Induced pluripotent stem cell technology for the study of human disease
    Gabsang Lee, Lorenz Studer · 2009 · Nature Methods
  73. Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis
    Luis B. Tovar‐y‐Romo, Luz Diana Santa-Cruz, Ricardo Tapia · 2009 · Molecular Neurodegeneration
  74. Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS
    Daniel Cacabelos, Omar Ramírez‐Núñez, Ana Belén Granado‐Serrano, Pascual Torres, Victòria Ayala, Victoria Moiseeva, Mónica Povedano, Isidró Ferrer, Reinald Pamplona, Manuel Portero‐Otín et al. · 2016 · Acta Neuropathologica Communications
  75. Defects in Motoneuron–Astrocyte Interactions in Spinal Muscular Atrophy
    Chunyi Zhou, Zhihua Feng, Chien‐Ping Ko · 2016 · Journal of Neuroscience
  76. The role of glia in protein aggregation
    Qingyun Li, Michael Seamus Haney · 2020 · Neurobiology of Disease
  77. Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS
    Ana G. Barbeito, Laura Martínez Palma, Marcelo R. Vargas, Mariana Pehar, Nelly Mañáy, Joseph S. Beckman, Luis Barbeito, Patricia Cassina · 2009 · Neurobiology of Disease
  78. Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS)
    Lindsay Poppe, Laura Rué, Wim Robberecht, Ludo Van Den Bosch · 2014 · Experimental Neurology
  79. Good, bad, and neglectful: Astrocyte changes in neurodegenerative disease
    Zoeb Jiwaji, Giles E. Hardingham · 2022 · Free Radical Biology and Medicine
  80. Advances in stem cell research for Amyotrophic Lateral Sclerosis
    Sophia T. Papadeas, Nicholas John Maragakis · 2009 · Current Opinion in Biotechnology
  81. Emerging drugs for amyotrophic lateral sclerosis
    Ali Aamer Habib, Hiroshi Mitsumoto · 2011 · Expert Opinion on Emerging Drugs
  82. Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis
    Cecilia Marini, Silvia Daniela Morbelli, Angelina Cistaro, Cristina Campi, Claudia Caponnetto, Matteo Bauckneht, Alessandro Bellini, Ambra Buschiazzo, Iolanda Calamia, Mauro Carlo Beltrametti et al. · 2018 · Brain
  83. In Vitro Modeling of Nerve–Muscle Connectivity in a Compartmentalized Tissue Culture Device
    Carolina Barcellos Machado, Perrine Pluchon, Peter Harley, Mark Rigby, Victoria Gonzalez Sabater, Danielle C. Stevenson, Stephanie Hynes, Andrew Lowe, Juan Burrone, Virgile Viasnoff et al. · 2019 · Advanced Biosystems
  84. Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow
    Vartika R. Mishra, Diane Bérangère Ré, Virginia Le Verche, Mariano J. Alvarez, Alessandro Vasciaveo, Arnaud Jacquier, Paschalis-Tomas Doulias, Todd M. Greco, Monica Nizzardo, Dimitra A. Papadimitriou et al. · 2020 · Nature Communications
  85. Enhanced SIRT6 activity abrogates the neurotoxic phenotype of astrocytes expressing ALS-linked mutant SOD1
    Harlan, Benjamin A., Pehar, Mariana, Killoy, Kelby M., Vargas, Marcelo R. · 2019 · The FASEB Journal
  86. Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase
    Gowing, Genevieve, Lalancette-Hébert, Mélanie, Audet, Jean-Nicolas, Dequen, Florence, Julien, Jean-Pierre · 2009 · Experimental Neurology
  87. Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential
    Justin You, Mohieldin Youssef, Jhune Rizsan Santos, Jooyun Lee, Jeehye Park · 2023 · Biology
  88. Drug Discovery Models and Toxicity Testing Using Embryonic and Induced Pluripotent Stem-Cell-Derived Cardiac and Neuronal Cells
    Rahul S. Deshmukh, Krisztián A. Kovács, András Dinnyés · 2012 · Stem Cells International
  89. Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival
    Kim A. Staats, Ludo Van Den Bosch · 2009 · Journal of Biological Physics
  90. Transcriptional profile of primary astrocytes expressing ALS‐linked mutant SOD1
    Marcelo R. Vargas, Mariana Pehar, Pablo Díaz‐Amarilla, Joseph S. Beckman, Luis Barbeito · 2008 · Journal of Neuroscience Research
  91. Forward engineering neuronal diversity using direct reprogramming
    Rachel K. Tsunemoto, Kevin Eade, Joel Blanchard, Kristin K. Baldwin · 2015 · The EMBO Journal
  92. Synaptotagmin 13 is neuroprotective across motor neuron diseases
    Monica Nizzardo, Michela Maria Taiana, Federica Rizzo, Julio Aguila Benitez, Jik Nijssen, Ilary Allodi, Valentina Melzi, Nereo Bresolin, Giacomo P. Comi, Eva Hedlund et al. · 2020 · Acta Neuropathologica
  93. Neural Regeneration
    Melissa Steward, Akshayalakshmi Sridhar, Jason S. Meyer · 2012 · Current topics in microbiology and immunology
  94. Impaired antioxydative Keap1/Nrf2 system and the downstream stress protein responses in the motor neuron of ALS model mice
    Takafumi Mimoto, Kazunori Miyazaki, Nobutoshi Morimoto, Tomoko Kurata, Kota Satoh, Yoshio Ikeda, Koji Abe · 2012 · Brain Research
  95. An α2-Na/K ATPase/α-adducin complex in astrocytes triggers non–cell autonomous neurodegeneration
    Gilbert Gallardo, Jessica Barowski, John Ravits, Teepu Siddique, Jerry B. Lingrel, Janice Robertson, Hanno Steen, Azad Bonni · 2014 · Nature Neuroscience
  96. The Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral Sclerosis
    Burcin Ikiz, Mariano J. Alvarez, Diane Bérangère Ré, Virginia Le Verche, Kristin A. Politi, Francesco Lotti, Sudarshan Phani, Radhika Pradhan, Changhao Yu, Gist F. Croft et al. · 2015 · Cell Reports
  97. Intraspinal Injection of Human Umbilical Cord Blood-Derived Cells Is Neuroprotective in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
    Sarah Knippenberg, Nadine Thau, Kerstin Schwabe, Reinhard Dengler, Axel Schambach, Ralf Hass, Susanne Petri · 2011 · Neurodegenerative Diseases
  98. Accumulation of labile zinc in neurons and astrocytes in the spinal cords of G93A SOD-1 transgenic mice
    Jean Kim, Tae-Youn Kim, Jung Jin Hwang, Joo‐Yong Lee, Jin-Hee Shin, Byoung Joo Gwag, Jae‐Young Koh · 2009 · Neurobiology of Disease
  99. Involvement of quinolinic acid in the neuropathogenesis of amyotrophic lateral sclerosis.
    Jong-Min Lee, V. Tan, D. Lovejoy, N. Braidy, D. Rowe, B. Brew, G. Guillemin · 2017 · Neuropharmacology
  100. Revisiting the role of the innate immune complement system in ALS
    Sandra E. Parker, Angela M. Hanton, Stephen N. Stefanou, Peter G. Noakes, Trent M. Woodruff, John D. Lee · 2019 · Neurobiology of Disease